| ²é¿´: 695 | »Ø¸´: 0 | ||
°¢ÄÏhmilyгæ (СÓÐÃûÆø)
|
[ÇóÖú]
ÊɾúÌåµÄÕ³ÐÔÄ©¶ËÊÇָʲô£¿
|
|
дÁËһƪÊɾúÌåÈ«»ùÒò×éÐòÁÐ×¢Ê͵ÄÓ¢ÎÄÎÄÕ£¬×î½ü·µ»ØÐÞ¸ÄÒâ¼û£¬ÆäÖÐÓÐÒ»ÌõÊÇ˵¡°No identification of the physical ends of the phage is included in the manuscript¡± ÇëÎÊÕâÀïµÄphysical ends of the phageÊÇָʲô£¿ÊÇÊɾúÌåDNAµÄÕ³ÐÔÄ©¶Ë£¿»¹ÊÇʲô£¿ лл¸÷λ´óÏÀ£¡ |
» ²ÂÄãϲ»¶
Wnt-C59£ºPORCN°ÐÏò»¯Ñ§Ì½Õ룬WntÐźÅͨ·×è¶Ï»úÖÆÓë¿ÆÑÐÓ¦ÓÃÈ«½âÎö
ÒѾÓÐ0È˻ظ´
Fexaramine£º³¦µÀÏÞÖÆÐÔFXR»¯Ñ§Ì½Õ룬½á¹¹ÌØÕ÷ÓëÐźÅͨ·Ñо¿È«½âÎö
ÒѾÓÐ0È˻ظ´
»¯Ñ§¹¤³Ì¼°¹¤Òµ»¯Ñ§ÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ58È˻ظ´
NVS-STG2£º°ÐÏòSTING¿çĤÓòµÄ·Ö×Ó½ºÀ༤¶¯¼Á£¬½á¹¹ÌØÕ÷Óë¹Ñ¾Û»¯»úÖÆÑо¿È«½âÎö
ÒѾÓÐ0È˻ظ´
DOTA-GPC3ëÄ£¨CAS 3066439-94-6£©£ºË«¹¦ÄÜ·Ö×Ó̽ÕëǰÌåµÄ½á¹¹ÌØÕ÷Óë±ê¼ÇÓ¦ÓýâÎö
ÒѾÓÐ0È˻ظ´
¿ÆÑÐÓà TLR7/8 Ë«¼¤¶¯¼ÁÔõôѡ£¿ÏÖ»õÓëÖÊ¿ØÒªµã
ÒѾÓÐ0È˻ظ´
SEL120-34A HCl£ºCDK8/CDK19¸ßÑ¡ÔñÐÔ¼¤Ã¸ÒÖÖÆ¼Á
ÒѾÓÐ0È˻ظ´
ÇâÑõ»¯¼Ø»î»¯²Ù×÷
ÒѾÓÐ18È˻ظ´
É¢½ð
ÒѾÓÐ68È˻ظ´
ÉúÎïÖʳ¬¼¶µçÈÝÆ÷
ÒѾÓÐ0È˻ظ´









»Ø¸´´ËÂ¥
28